Connect Biopharma is trading at $2.19 (5.3% up) on thin after-hours liquidity following a regular-session close of $2.08.
- The price action mirrors similar extended-hours strength observed on July 27, 2026, which was also driven by light volume.
- No new earnings, FDA updates, M&A activity, or major company-specific headlines have been identified to account for the move.